Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E V Capparelli

Showing results (41-50 of 45) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 45 results.
HIV Medicine|September 18, 2008
Pharmacokinetics of new 625 mg nelfinavir formulation during pregnancy and postpartumJ S Read, B M Best, A M Stek, et al.
Clinical Pharmacology and Therapeutics|June 21, 2014
Use of opportunistic clinical data and a population pharmacokinetic model to support dosing of clindamycin for premature infants to adolescentsD Gonzalez, C Melloni, R Yogev, et al.
HIV Medicine|March 28, 2008
Chronic administration of nevirapine during pregnancy: impact of pregnancy on pharmacokineticsE V Capparelli, F Aweeka, J Hitti, et al.
Clinical Pharmacology and Therapeutics|January 2, 2009
Abacavir pharmacokinetics during chronic therapy in HIV-1-infected adolescents and young adultsJ W Sleasman, B L Robbins, S J Cross, et al.
The Journal of Infectious Diseases|November 9, 2000
Oral ganciclovir in children: pharmacokinetics, safety, tolerance, and antiviral effects. The Pediatric AIDS Clinical Trials GroupL M Frenkel, E V Capparelli, W M Dankner, et al.
Pageof 5

Showing results (41-50 of 45) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 45 results.
HIV Medicine|September 18, 2008
Pharmacokinetics of new 625 mg nelfinavir formulation during pregnancy and postpartumJ S Read, B M Best, A M Stek, et al.
Clinical Pharmacology and Therapeutics|June 21, 2014
Use of opportunistic clinical data and a population pharmacokinetic model to support dosing of clindamycin for premature infants to adolescentsD Gonzalez, C Melloni, R Yogev, et al.
HIV Medicine|March 28, 2008
Chronic administration of nevirapine during pregnancy: impact of pregnancy on pharmacokineticsE V Capparelli, F Aweeka, J Hitti, et al.
Clinical Pharmacology and Therapeutics|January 2, 2009
Abacavir pharmacokinetics during chronic therapy in HIV-1-infected adolescents and young adultsJ W Sleasman, B L Robbins, S J Cross, et al.
The Journal of Infectious Diseases|November 9, 2000
Oral ganciclovir in children: pharmacokinetics, safety, tolerance, and antiviral effects. The Pediatric AIDS Clinical Trials GroupL M Frenkel, E V Capparelli, W M Dankner, et al.
Pageof 5